Back
Nektar Therapeutics Stock Price Chart
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Buy
62
NKTR
Nektar Therapeutics
Last Price:
1.64
Seasonality Move:
-2.31%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.42 | Buy |
| 20-day SMA: | 1.41 | Buy |
| 50-day SMA: | 1.07 | Buy |
| 200-day SMA: | 0.7 | Buy |
| 8-day EMA: | 1.45 | Buy |
| 20-day EMA: | 1.35 | Buy |
| 50-day EMA: | 1.13 | Buy |
| 200-day EMA: | 0.99 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 68.48 | Buy |
| Chaikin Money Flow: | 1645424 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.09 - 1.53) | Buy |
| Bollinger Bands (100): | (0.49 - 1.15) | Buy |
Nektar Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
- Nektar Therapeutics share price is 1.65 while NKTR 8-day simple moving average is 1.42, which is a Buy signal.
- The stock price of NKTR is 1.65 while Nektar Therapeutics 20-day SMA is 1.41, which makes it a Buy.
- Nektar Therapeutics 50-day simple moving average is 1.07 while NKTR share price is 1.65, making it a Buy technically.
- NKTR stock price is 1.65 and Nektar Therapeutics 200-day simple moving average is 0.70, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Buy
62
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a Buy
The current Nektar Therapeutics [NKTR] share price is $1.65. The Score for NKTR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
302.97M
Price in USD:
1.65
Share Volume:
1.65M
Nektar Therapeutics 52-Week Range
52-Week High:
1.75
52-Week Low:
0.41
Buy
62
Nektar Therapeutics (NKTR)
is a Buy
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?
The Nektar Therapeutics stock price is 1.65 USD today. -
Will NKTR stock go up or go down?
Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Nektar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is not overvalued.
Is Nektar Therapeutics Stock a Buy?
- Nektar Therapeutics share price is 1.65 while NKTR 8-day exponential moving average is 1.45, which is a Buy signal.
- The stock price of NKTR is 1.65 while Nektar Therapeutics 20-day EMA is 1.35, which makes it a Buy.
- Nektar Therapeutics 50-day exponential moving average is 1.13 while NKTR share price is 1.65, making it a Buy technically.
- NKTR stock price is 1.65 and Nektar Therapeutics 200-day simple moving average is 0.99, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.06 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
- NKTR Moving Average Covergence Divergence (MACD) indicator is 0.12, suggesting Nektar Therapeutics is a Buy
- Nektar Therapeutics Relative Strength Index (RSI) is 68.48, which suggest Nektar Therapeutics is overbought
- The Bollinger Bands (25) for Nektar Therapeutics is (1.09 - 1.53), which suggest Nektar Therapeutics is a Buy
- The Bollinger Bands (100) for Nektar Therapeutics is (0.49 - 1.15), which suggest Nektar Therapeutics is a Buy
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.